A heterogeneous human immunodeficiency virus-like particle (VLP) formulation produced by a novel vector system

First identified as the etiological agent behind Acquired Immunodeficiency Syndrome (AIDS) in the early 1980s, HIV-1 has continued to spread into a global pandemic and major public health concern. Despite the success of antiretroviral therapy at reducing HIV-1 viremia and preventing the dramatic CD4...

Descripción completa

Detalles Bibliográficos
Autores principales: Pankrac, Joshua, Klein, Katja, McKay, Paul F., King, Deborah F. L., Bain, Katie, Knapp, Jason, Biru, Tsigereda, Wijewardhana, Chanuka N., Pawa, Rahul, Canaday, David H., Gao, Yong, Fidler, Sarah, Shattock, Robin J., Arts, Eric J., Mann, Jamie F. S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5775397/
https://www.ncbi.nlm.nih.gov/pubmed/29367885
http://dx.doi.org/10.1038/s41541-017-0040-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5775397/
https://www.ncbi.nlm.nih.gov/pubmed/29367885
http://dx.doi.org/10.1038/s41541-017-0040-6

Ejemplares similares